{
    "clinical_study": {
        "@rank": "29918", 
        "arm_group": [
            {
                "arm_group_label": "Healthy controls (HC)", 
                "description": "HC"
            }, 
            {
                "arm_group_label": "Inflammatory Bowel Disease (IBD) patients", 
                "description": "Crohn's disease (CD), Ulcerative colitis (UC) and pouchitis"
            }
        ], 
        "biospec_descr": {
            "textblock": "Fecal samples"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel\n      Disease(IBD) patients versus healthy controls (HC)."
        }, 
        "brief_title": "Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Inflammatory Bowel Diseases", 
        "condition_browse": {
            "mesh_term": [
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of IBD\n\n          -  Age >18 years\n\n        Exclusion Criteria:\n\n          -  Use of antibiotics in the preceding month\n\n          -  Intake of pre- or probiotics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "204", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01666717", 
            "org_study_id": "ML4355_VOC"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 16, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Vlaams-Brabant", 
                    "zip": "3000"
                }, 
                "name": "KULeuven-UZLeuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "2", 
        "official_title": "Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01666717"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Katholieke Universiteit Leuven", 
            "investigator_full_name": "Kristin Verbeke", 
            "investigator_title": "Professor K. Verbeke", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Katholieke Universiteit Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Katholieke Universiteit Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}